Andrew Spaventa - 12 May 2024 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
OMIC
Transactions as of
12 May 2024
Transactions value $
$0
Form type
4
Filing time
13 May 2024, 19:00:21 UTC
Previous filing
19 Mar 2024
Next filing
18 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +57.2K +585.58% 67K 12 May 2024 Direct F1
transaction OMIC Common Stock Gift $0 -57.2K -85.41% $0.00 9.77K 12 May 2024 Direct F2
transaction OMIC Common Stock Gift $0 +57.2K +1.4% $0.00 4.15M 12 May 2024 By The Andrew K. Spaventa Living Trust dated April 9, 2014 F2
holding OMIC Common Stock 2.57K 12 May 2024 By Axon Holdings, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise $0 -57.2K -6.25% $0.00 858K 12 May 2024 Common Stock 57.2K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Immediately upon vesting of the Reporting Person's RSUs, the Reporting Person transferred his shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
F3 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4 The RSUs vest in 16 equal quarterly installments over four years measured from February 12, 2024.